Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. - Wikidata - awgldk - TriplyDB

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

http://www.wikidata.org/entity/Q33342842

about

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review Osteosarcoma in Korean children and adolescents Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin Pazopanib in the treatment of soft tissue sarcoma EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group Study Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.The evolution of systemic therapy in sarcoma.Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.Trabectedin and its potential in the treatment of soft tissue sarcoma.Trabectedin for the management of soft-tissue sarcoma.Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG).A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer.A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma.A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis Role of expert centres in the management of sarcomas Clinical management of secondary angiosarcoma after breast conservation therapy Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Role of trabectedin in the treatment of soft tissue sarcoma Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature Diagnosis and treatment of sarcoma of the uterus. A review.Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature.Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.Epidemiology and therapies for metastatic sarcoma Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series Recent advances in understanding and managing leiomyosarcomas

P2860

Q24685605-0438E4C8-9FCC-4525-8BB8-F3D1CEC1EEBD Q26822530-17797287-D8C2-4465-9535-25C91DB769E8 Q28083794-261A85A8-1FB4-45EE-B1B7-11C08E80AB73 Q28087771-8F2CF39D-4678-4544-8002-443AE6B7FA20 Q28269229-01B5E28D-67A3-42ED-9B8B-6EE211A419C1 Q28484249-01F03612-6FC9-4385-BB0D-9C298A346755 Q30370631-26F3789D-AF97-40AF-B014-7702C23F2C8D Q30439459-2F4BB747-C4E5-4EB8-8119-2E909606B834 Q33274710-D9D08640-F95E-4984-A4E5-BD2246AA7806 Q33362634-224F64F3-5622-4CA6-A38B-C0C31CB47D02 Q33379886-8ED4798F-7D71-44CC-8566-AC34043AF3AD Q33380903-9B1DBB03-B41A-4EE2-B878-067AEF57C32B Q33384836-F59D231D-ADDC-4A8C-8E9F-C92991EF9F7C Q33386535-5F4CB862-F254-4F6E-B64F-2652FAC7F819 Q33397403-90517C25-FB6D-4596-AF5B-342B25678C5D Q33399473-1607E4A9-8F0A-43B3-93AE-2072C404B9ED Q33400419-9E09542B-50DE-4E7B-AE71-CB4CD24CC51C Q33419792-29519A0B-DA7D-4E36-AAF9-63C6AE177F80 Q33423308-4790F510-34DE-4794-A633-B0B21D9DE1DB Q33427160-775D831C-7744-4BFC-8CB3-1BD891595AE9 Q33438485-F60BD25D-8936-4B73-87DA-B41E0446F711 Q33439510-F25565A7-982A-41E6-8C24-A9A3F4CB8980 Q33523297-C01E8968-2D6D-4148-9FBE-E37D95963E38 Q33657779-8CFB085C-E779-4652-B50D-8EFDE8AC3086 Q33697957-1060FBBA-895B-491E-ADA5-81D635626D1E Q33751719-DBD45487-193A-47EE-B91A-619EBF609E54 Q33829625-1D99E704-A57D-4416-8389-923F5E4A6827 Q33844215-A98B9CC6-41FF-4024-A158-038370B1EEB8 Q33891037-8BF00711-F4D0-4A13-8B03-D2CC597F9982 Q33916011-EA4ECDF3-963B-4602-9C65-1E5552E7D1A1 Q33975569-D24FFEF3-101E-404E-9A24-7809B8F2EE44 Q34336818-BC7F6561-F33F-4596-B67B-370958100A3B Q34343122-C699DA09-36D6-40DA-9588-E90AC1A6E13D Q34360332-7BF4E5CA-668C-48B9-BE85-6A97CADE3F62 Q34387629-93C99BAD-CFFC-4890-BCA1-AA60DEE8B478 Q34413659-ACCC2808-DACB-4B30-81F5-4AEAD581B4B7 Q34432570-F8F2FA6B-19B6-4F00-A31E-0522AF8422AE Q34652142-96171390-C663-4344-88E9-A8479E6226DB Q34669352-74FA4D45-05A9-4DC7-9542-23B8DD416BDF Q34670825-161F7A89-D152-4B69-A555-B3998BACD191

P2860

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

http://www.wikidata.org/entity/Q33342842

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@ast

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@en

type

label

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@ast

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@en

prefLabel

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@ast

Gemcitabine and docetaxel in p ...... : results of a phase II trial.

@en

P1433

Q33342842-6375831B-4835-497D-8D22-E47FA63E5A19

P1476

Q33342842-F06035AD-BACE-4091-A8E8-11CD35266CEB

P2093

Q33342842-183AEB3A-93E0-4F25-ADDE-A10C285039A4

Q33342842-19B2DCE2-0F64-48FA-BE06-3EA67AADB2C4

Q33342842-4556F643-0954-4FBB-9ECE-6103CB4E8F9E

Q33342842-BF9EFB7C-C58A-48BD-AA0A-F28CE2DDAB51

Q33342842-C48445AD-426C-40E2-8537-BF5F1A49DD01

Q33342842-CD46D673-CBD2-494B-8FC1-82D5FCDB8A77

Q33342842-D618FE25-82F4-405D-BEF2-7619FC230EBA

Q33342842-D6BF90DC-A3E9-440A-A8E2-ED9689F3B640

Q33342842-F88F0BD6-D1EF-45B6-92C6-505C7F0F154F

P304

Q33342842-48E9BADF-311D-4279-8F4F-FCD73DC13979

P31

Q33342842-D3029E62-CCF3-438E-9FE1-B4DCBD3CB9CA

P356

Q33342842-3E83FCED-64A4-4EE0-B656-588F3EA2A198

P407

Q33342842-B89D3B03-9277-4028-B145-2671FB716B89

P433

Q33342842-26A146C9-11AC-48FA-83A7-F37F58439125

P478

Q33342842-99D86BB4-87D2-4346-9FC7-095B9499CF5B

P50

Q33342842-99DF86A6-A43A-4358-BF6D-D644F4F62309

P577

Q33342842-D2A494F7-105D-472C-B68D-C23F390ACED2

P698

Q33342842-BB04B525-DC3A-42CB-978E-94CC3CFFEB94

P921

Q33342842-EADFECFB-9DC2-4888-978A-315DF4946FC1

P356

JCO.2002.11.050

P1433

Journal of Clinical Oncology

P1476

Gemcitabine and docetaxel in p ...... a: results of a phase II trial

@en

P2093

Carol Aghajanian

http://www.w3.org/2001/XMLSchema#string

David R Spriggs

http://www.w3.org/2001/XMLSchema#string

E Venkatraman

http://www.w3.org/2001/XMLSchema#string

Gennifer Geller

http://www.w3.org/2001/XMLSchema#string

Martee L Hensley

http://www.w3.org/2001/XMLSchema#string

Meghan Lovegren

http://www.w3.org/2001/XMLSchema#string

Paul Sabbatini

http://www.w3.org/2001/XMLSchema#string

Richard Barakat

http://www.w3.org/2001/XMLSchema#string

William Tong

http://www.w3.org/2001/XMLSchema#string

P304

2824-2831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2002.11.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12065559

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial